55 Participants Needed

Ischemic Conditioning for Stroke

(PLM Trial)

JN
AW
Overseen ByAlicen Whitaker-Hilbig, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Medical College of Wisconsin
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

Stroke survivors have compromised vascular function which may contribute to secondary stroke risk, cardiovascular disease, and may limit their exercise tolerance. No studies have examined how femoral blood flow responds to both passive leg movement, a measure of microvascular function, as well as active leg contractions, a measure of the hyperemic response to exercise. Leg muscles with a reduced blood flow response to movement could be associated with decreased neuromuscular function, such as leg strength and fatigue. Preliminary data showing a single bout of ischemic conditioning may improve vascular function and muscle activation in healthy adults and individuals post-stroke. Therefore, the investigators want to examine if ischemic conditioning will also improve the blood flow response to passive leg movements as well as during single leg active contractions.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Ischemic Conditioning for Stroke?

Research suggests that remote ischemic conditioning (RIC) may help improve outcomes for stroke patients by protecting brain cells and reducing inflammation. Some studies show it could be beneficial when used soon after a stroke, and it might also help with recovery by supporting brain repair.12345

How is remote ischemic conditioning different from other stroke treatments?

Remote ischemic conditioning (RIC) is unique because it involves temporarily restricting blood flow to a limb, like using a blood pressure cuff, to protect the brain during a stroke. This noninvasive method is different from standard treatments like clot-busting drugs or surgery, as it aims to enhance the body's natural protective responses without directly targeting the stroke site.16789

Research Team

MD

Matthew Durand, PhD

Principal Investigator

Medical College of Wisconsin

Eligibility Criteria

This trial is for stroke survivors aged 18-85 with residual hemiparesis from a stroke at least 6 months prior, and healthy adults aged 18-30. Participants must be able to understand instructions and communicate in English. Exclusions include severe mobility issues, recent severe COVID-19 or head trauma, other neurological disorders, heart attack within the last year, high blood pressure, pregnancy/breastfeeding, or conditions where leg compression is unsafe.

Inclusion Criteria

I had a stroke 6+ months ago, have some paralysis, can follow commands, and speak English.

Exclusion Criteria

Other significant medical condition likely to influence study or jeopardize safety as assessed by the Primary Investigator
I have not had a head injury or concussion in the last 6 months.
I have had a heart attack in the last year.
See 10 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo ischemic conditioning with varying cuff pressures to assess effects on leg blood flow and muscle function

1 day per session
Multiple sessions (in-person)

Follow-up

Participants are monitored for changes in femoral blood flow and muscle function after ischemic conditioning

3 hours post-treatment

Post-Conditioning Assessment

Assessment of femoral blood flow response to neuromuscular fatigue task

15 minutes post-conditioning

Treatment Details

Interventions

  • Ischemic Conditioning
Trial Overview The study investigates whether ischemic conditioning can improve blood flow response during passive and active leg movements in individuals post-stroke. It aims to see if this treatment could enhance vascular function and muscle activation which might be compromised after a stroke.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Ischemic Conditioning - LowExperimental Treatment1 Intervention
During each testing session, the investigators will be measuring how one treatment of ischemic conditioning effects leg blood flow and muscle function. One day participants will receive a low cuff inflation pressure on the leg, called ischemic conditioning - low (25 mmHg).
Group II: Ischemic Conditioning - HighExperimental Treatment1 Intervention
During each testing session, the investigators will be measuring how one treatment of ischemic conditioning effects leg blood flow and muscle function. One day participants will receive a high cuff inflation pressure on the leg, called ischemic conditioning - high (225 mmHg).

Find a Clinic Near You

Who Is Running the Clinical Trial?

Medical College of Wisconsin

Lead Sponsor

Trials
645
Recruited
1,180,000+

Marquette University

Collaborator

Trials
68
Recruited
202,000+

Findings from Research

The SERIC-IVT trial is evaluating the effectiveness and safety of remote ischemic conditioning (RIC) combined with intravenous thrombolysis (IVT) in 558 patients with acute ischemic stroke, aiming to improve functional outcomes at 90 days.
The study will assess whether RIC can lead to a 13.14% increase in favorable outcomes, measured by the modified Rankin Scale, while also monitoring for safety issues such as mortality and adverse events within the same period.
Safety and efficacy of remote ischemic conditioning combined with intravenous thrombolysis for acute ischemic stroke: A multicenter, randomized, parallel-controlled clinical trial (SERIC-IVT) Study design and protocol.Abuduxukuer, R., Guo, ZN., Zhang, P., et al.[2023]
In a study of 27 patients with hemiplegia from acute ischemic stroke, chronic remote ischemic conditioning (RIC) for 90 days significantly improved lower limb motor function compared to the control group, as indicated by higher Fugl-Meyer Assessment scores.
Chronic RIC also led to a significant increase in serum levels of epidermal growth factor (EGF), suggesting a potential mechanism for its beneficial effects on recovery, although overall functional outcomes did not show a significant difference.
Remote Ischemic Conditioning for Motor Recovery after Acute Ischemic Stroke.Yu, W., Ren, C., Du, J., et al.[2023]
In a study of 1,776 patients with acute moderate ischemic stroke, early initiation of Remote Ischemic Conditioning (RIC) within 24 hours of stroke onset was associated with an 8.1% higher likelihood of achieving excellent functional outcomes at 90 days compared to usual care.
No significant benefits were observed for patients who received RIC treatment later (24-48 hours after onset) compared to the control group, indicating that timing of RIC is crucial for its effectiveness.
Time from Onset to Remote Ischemic Conditioning and Clinical Outcome After Acute Moderate Ischemic Stroke.Cui, Y., Chen, YN., Nguyen, TN., et al.[2023]

References

Safety and efficacy of remote ischemic conditioning combined with intravenous thrombolysis for acute ischemic stroke: A multicenter, randomized, parallel-controlled clinical trial (SERIC-IVT) Study design and protocol. [2023]
Remote Ischemic Conditioning for Motor Recovery after Acute Ischemic Stroke. [2023]
Time from Onset to Remote Ischemic Conditioning and Clinical Outcome After Acute Moderate Ischemic Stroke. [2023]
Potential Anti-Inflammatory and Anti-Coagulation Effects of One-Time Application of Remote Ischemic Conditioning in Patients With Subacute/Chronic Cerebral Arteriostenosis and Venostenosis. [2023]
A review of remote ischemic conditioning as a potential strategy for neural repair poststroke. [2023]
Remote ischemic conditioning for acute stroke patients treated with thrombectomy. [2022]
Efficacy and safety of remote ischemic conditioning for acute ischemic stroke: A comprehensive meta-analysis from randomized controlled trials. [2023]
Remote Ischemic Conditioning in Ischemic Stroke and Myocardial Infarction: Similarities and Differences. [2021]
Remote Limb Ischemic Conditioning during Cerebral Ischemia Reduces Infarct Size through Enhanced Collateral Circulation in Murine Focal Cerebral Ischemia. [2018]